Smith & Nephew plc (LON:SN)
1,105.00
-12.50 (-1.12%)
May 7, 2026, 2:01 PM GMT
Smith & Nephew Revenue
In the year 2025, Smith & Nephew had annual revenue of $6.16B USD with 6.09% growth. Smith & Nephew had revenue of $3.20B in the half year ending December 31, 2025, with 13.78% growth.
Revenue
$6.16B
Revenue Growth
+6.09%
P/S Ratio
2.08
Revenue / Employee
$362.84K
Employees
16,988
Market Cap
9.54B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16B | 354.00M | 6.09% |
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
| Dec 31, 2018 | 4.90B | 139.00M | 2.92% |
| Dec 31, 2017 | 4.77B | 96.00M | 2.06% |
| Dec 31, 2016 | 4.67B | 35.00M | 0.76% |
| Dec 31, 2015 | 4.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Hikma Pharmaceuticals | 2.49B |
| Convatec Group | 1.81B |
| CVS Group | 692.80M |
| Genus | 672.00M |
| HUTCHMED (China) | 407.54M |
Smith & Nephew News
- 1 day ago - Smith & Nephew Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises - Reuters
- 1 day ago - Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026 - GlobeNewsWire
- 8 days ago - Is Smith & Nephew PLC (SNN) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
- 15 days ago - A Look at Smith & Nephew PLC (SNN) After 4.0% Decline -- GF Value $31.12 vs Price $32.84 - GuruFocus
- 15 days ago - Smith+Nephew (SNN) Reports Positive Trial Results for Cartilage Repair Implant - GuruFocus
- 22 days ago - Smith & Nephew Breaks Above 200-Day Moving Average - Bullish for SNN - Nasdaq
- 27 days ago - Smith & Nephew (SNN) Reports Positive Trial Results for Rotator Cuff Implant - GuruFocus